Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$39.45 – $57.22
2% from low
Exchange
OTC Link
ADRC
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.61B | $12.57B | $13.45B | $15.78B | $18.69B | $18.12B | $17.98B | $16.78B |
| Cost of revenue | $4.03B | $4.99B | $6.15B | $7.09B | $9.55B | $9.08B | $8.42B | $7.63B |
| Gross profit | $6.57B | $7.58B | $7.30B | $8.68B | $9.13B | $9.04B | $9.56B | $9.16B |
| Gross margin | 62.0% | 60.3% | 54.3% | 55.0% | 48.9% | 49.9% | 53.2% | 54.6% |
| R&D | $861.0M | $981.0M | $1.15B | $1.39B | $1.41B | $1.55B | $1.49B | $1.46B |
| Operating income | $1.80B | $2.00B | $1.63B | $2.40B | $1.11B | $869.0M | $1.86B | $1.60B |
| EBITDA | $2.35B | $2.99B | $2.71B | $3.48B | $2.40B | $2.40B | $3.12B | $2.65B |
| Net income | $1.24B | $1.45B | $1.25B | $1.76B | $511.0M | $228.0M | $988.0M | $653.0M |
| Net margin | 11.7% | 11.6% | 9.3% | 11.1% | 2.7% | 1.3% | 5.5% | 3.9% |
| EPS (diluted) | 27.39 | 32.94 | 28.89 | 40.47 | 11.97 | 4.92 | 20.34 | 12.93 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $10.8B | $23.29 | $23.13–$23.39 | 1 |
| 2027 | $18.3B | $30.48 | $30.26–$30.60 | 1 |
| 2028 | $19.2B | $36.43 | $36.17–$36.58 | 1 |
| 2029 | $20.3B | $47.41 | $47.07–$47.61 | 1 |
Forward consensus · source: Financial Modeling Prep
GN STORE NORD A/S ADR
No one on the platform currently holds GNNDY.
No tracked institution reports a position in GNNDY as of their last filing.
No one on the platform has traded GNNDY yet.
| +0.00% |
| $1.8B |
| — |
| OSSUYEmbla Medical hf. | $3.81 | +0.00% | $1.6B | — |
| STSEYStratec SE | $5.51 | +0.00% | $1.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 2.4× earnings vs its 4.8× historical median P/E.
Fair value ≈ $79.17 · price $39.89 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.